14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IPSC
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in Century Therapeutics, Inc. stock price on Wednesday moving 11.83% between high and low
(Updated on Apr 24, 2024)

Sell candidate since Apr 16, 2024 Loss -5.73% PDF

The Century Therapeutics, Inc. stock price fell by -5.43% on the last day (Wednesday, 24th Apr 2024) from $3.13 to $2.96. During the last trading day the stock fluctuated 11.83% from a day low at $2.79 to a day high of $3.12. The price has fallen in 6 of the last 10 days and is down by -21.69% for this period. Volume has increased on the last day by 59 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 134 thousand shares were bought and sold for approximately $396.90 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.76 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -17.24% during the next 3 months and, with a 90% probability hold a price between $2.28 and $3.96 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IPSC Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, April 17, 2024, and so far it has risen 4.23%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Century Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.03 and $4.09. A break-up above any of these levels will issue buy signals. Century Therapeutics, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Century Therapeutics, Inc. stock

Century Therapeutics, Inc. finds support from accumulated volume at $2.84 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.330 between high and low, or 11.83%. For the last week, the stock has had daily average volatility of 13.28%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IPSC) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Century Therapeutics, Inc. to open at $2.96, and during the day (based on 14 day Average True Range), to move between $2.57 and $3.35, which gives a possible trading interval of +/-$0.394 (+/-13.29%) up or down from last closing price. If Century Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 26.59% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.98 (0.51%) than the support at $2.84 (4.05%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Century Therapeutics, Inc. stock A Buy?

Century Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.701 Sell Candidate Unchanged

Predicted Opening Price for Century Therapeutics, Inc. of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$2.96 ( 0.113%) $2.96

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IPSC

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.29 11.04 %
R2 3.16 6.78 %
R1 3.08 4.15 %
Current price: 2.96
Support S1 2.83 -4.37 %
S2 2.75 -7.00 %
S3 2.63 -11.26 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.67 23.99 %
R2 3.14 6.08 %
R1 2.98 0.507 %
Current price 2.96
Support S1 2.84 -4.05%
S2 0 .
S3 0 .

FAQ

What is the symbol for Century Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Century Therapeutics, Inc. is IPSC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Century Therapeutics, Inc. Stock?
Century Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Century Therapeutics, Inc. Stock?
Century Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Century Therapeutics, Inc. Stock.

What's the current price of Century Therapeutics, Inc. Stock?
As of the end of day on the Apr 24, 2024, the price of an Century Therapeutics, Inc. (IPSC) share was $2.96.

What is the 52-week high and low for Century Therapeutics, Inc. Stock?
The 52-week high for Century Therapeutics, Inc. Stock is $5.50 and the 52-week low is $1.28.

What is the market capitalization of Century Therapeutics, Inc. Stock?
As of the Apr 24, 2024, the market capitalization of Century Therapeutics, Inc. is 203.214M.

When is the next earnings date for Century Therapeutics, Inc.?
The upcoming earnings date for Century Therapeutics, Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Century Therapeutics, Inc.

Century Therapeutics. Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting C... IPSC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT